SMAD2 and lung carcinoma: Figure 5C depicts the decreased SMAD2 level in lung cancer cells after transfection with si-LINC01132 compared with the si-NC group, while the involvement of miR-125a-3p inhibitor reversed the inhibition of SMAD2 level by silencing LINC01132.